TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
Ningxia recently published a batch of drugs off for 15 is essential drugs
 
Author:中国铭铉 企划部  Release Time:2017-4-1 10:16:32  Number Browse:516
 
Medical network - on April 1, another group of hospital drug procurement is not here, among the 15 is medicine. 
 
March 31, the national medicine GuanPing notice, publicize the ningxia recent supply, or normal supply of drugs directory. 
 
▍ out of stock, not normal supply, 16 drugs or waste 
 
Ningxia medicine in the notice of action, according to the part of the bid prices for medicines, GMP certificate due reasons, such as production enterprises supply, or normal supply situation, the serious influence to ensure clinical medication of medical institutions. The aspects of the public, these products in ningxia and cancel its bid qualification as a punishment. (see the appendix of furniture list for detail) 
 
In addition, if there is drug firms to object to the directory of the public by, ningxia medicine manages to appeal period of 7 days -- from March 30 - April 7, submit the complaint in the form of enterprise official documents. Overdue don't complaint or not true situation, will press concerned regulation processing. 
 
What need reminds is, the appeal of reserved 7 days period, subtracted tomb-sweeping day off for three days, the rest of the time is not comfortable. 
 
▍ price factor, which is broken for the cause 
 
Although the reason for the given drugs out of stock in ningxia's conclusion: price or GMP certificate expires, etc. However, if you look at the product won the bid prices in the catalog, would rather believe that the most important factor is that due to price reasons, companies would rather buy the mark, results in waste of flatly adopted this way. 
 
16 products, there are 11 priced under $2, more for injection, commonly known as "small water". Profit is not high, depends on quantity. Due to reasons known to all, it happened that most of the hospital on the use of these cheap drugs, not be very enthusiastic, shrinking market, no sales profit, the enterprise is lack of power production and promotion. 
 
Another kind of circumstance is disequilibrium price, such as "strong bone joints pill" China resources base in the medicine price is 8.93 yuan, and the same specifications of the market retail price of 18 yuan (health attracts), perhaps drug firms in the market planning, supply a tendency toward priority profits more lucrative one. 
 
▍ cheap medicines, is a delete key 
 
This kind of thing not seen many times, the latest is liaoning health development planning commission issued a notice physical a week ago, there are 57 hospital drug procurement, including some nasty (rob) save products, some products price didn't wind up, some even no enterprise willing to bid. 
 
And ningxia, as most of foreclosures is cheap medicine. With these information, let a person vaguely jittery. These products seem to have entered a key to "delete" pattern, may disappear quickly, at any time from positive meaning can be said to be the new, metabolic change; But on the other hand, always feel that is a pity, because substitute for these drugs are expensive. 
 
Solutions, and countries such as version: take the designated production, pharmaceutical reserve, emergency production, negotiate, adjust measures to ensure that supply. Beijing's version of such as: clinical treatment must and irreplaceable shortage of cheap drugs, the net purchase directly, no longer set the national minimum reference. 
 
Group after group of drugs, eye watched. Hope more hurry up on the implementation of these solutions. 
 
Previous article:Shaanxi province to push drug consumables purchasing New Deal "with the amount of negotiation"
Next article:The standing committee of the National People's Congress will go to the pharmaceutical administration law enforcement examination was conducted for 8 provinces (municipalities)
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粤公网安备 44011202000029号